SS-31 (Elamipretide) is a precision mitochondrial peptide that targets cardiolipin on the inner mitochondrial membrane — the only compound known to reach and stabilize this specific architecture at therapeutic concentrations. Phase II human trials in heart failure (HFpEF) and Barth syndrome have earned FDA Breakthrough Therapy Designation and Fast Track Designation.
Read the full research deep dive: /articles/ss-31-elamipretide
